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Objective: To determine whether the structure of chondroitin sulfate (CS) in cartilage is reﬂected by the
degree of cartilage degeneration in patients with osteoarthritis (OA) of the knee and to determine how CS
biosynthesis affects cartilage degeneration.
Design: Two osteoarthritic cartilage samples were obtained from medial femoral condyle (MFC) and
lateral femoral condyle (LFC) of 24 knees with end-stage OA. The samples were assigned to two groups as
follows: lesion and remote cartilage were adjacent to and remote from the osteoarthritic cartilage,
respectively. Histological grade was determined according to the Mankin score. The CS concentration and
chain length were determined using high-performance liquid chromatography (HPLC) and gel ﬁltration
chromatography, respectively. Expression of the gene encoding CS glycosyltransferase was evaluated
using a real-time quantitative polymerase chain reaction (qPCR) assay. These results were compared
between lesion and remote cartilage.
Results: The Mankin score indicated that lesion cartilage was more degraded compared with remote
cartilage. Although the CS levels varied among individuals, the mean CS concentration and chain length
were signiﬁcantly lower and shorter in lesion cartilage than in remote cartilage, respectively (concen-
tration: 12.04 vs 14.84 mg/mg wet weight, P ¼ 0.021; chain length: 5.36 vs 6.19 kDa, P ¼ 0.026). Three
genes encoding CS glycosyltransferases (CHPF, CSGALNACT1, CSGALNACT2) were expressed at lower levels
in lesion cartilage.
Conclusions: In the osteoarthritic knee, the CS concentration and chain length were reduced closer to the
more degraded cartilage with decreasing CS glycosyltransferase gene expression. Inhibition of CS gly-
cosyltransferase gene expression may reduce CS chain length, which may contribute to OA progression.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is themost common degenerative joint disease
and a leading cause of disability and joint pain1. OA is characterized by
progressivebreakdownof the articular cartilage,which is composedof
chondrocytes and a highly organized extracellular matrix (ECM).
Chondrocytesmaintainthenormal cartilageECMandsecrete catabolic
proteinases associated with OA progression2e4. The major structural
components of ECM are type-II collagen and proteoglycan aggregates,
including aggrecan, hyaluronan, and linkprotein. Aggrecan is themost
abundant proteoglycan aggregate with a large amount of chondroitinK. Matsumoto, Department of
ifu 501-1194, Japan. Tel: 81-
p (D. Ishimaru), nsugiura@
p (H. Akiyama), wannabee@
p (K. Matsumoto).
s Research Society International. Psulfate (CS) in cartilage5,6, and imparts gel-like properties to cartilage
such as lubrication, resistance to compression load, and water reten-
tion5e7. Approximately 100 CS chains are covalently linked to the core
protein of aggrecan, and the total molecular weight of aggrecan rea-
ches approximately 2200 kDa6,8,9. CS is a glycosaminoglycan (GAG)
that consists of repeating disaccharide residues, N-acetylgalactos-
amine (GalNAc) and glucuronic acid (GlcUA) with sulfate residues at
the 4- or 6-O-positions of GalNAc residues that are added in the Golgi
apparatus. CS synthesis starts after GalNAc residues attach to the
linkage site of a GlcUA-b1, 3-galactose (Gal)-b1, 3-Gal-b1, 4-Xylose
tetrasaccharide that is covalently coupled through serine residues of
the core protein, followed by polymerization that progresses via the
addition of GlcUA and GalNAc residues10. Glycosyltransferase-I has a
role of initiation of CS chain, and glycosyltransferase-II elongates it11.
Six glycosyltransferases have been identiﬁed to be involved in CS
biosynthesis in mammals as follows: chondroitin sulfate synthase 1
(CSS1/CHSY1)12, chondroitin polymerizing factor (CHPF)13, chon-
droitin sulfate synthase 3 (CSS3)14, chondroitin polymerizing factor 2ublished by Elsevier Ltd. All rights reserved.
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(CSGALNACT1)16, and chondroitin sulfate N-acetylgalactosaminyl-
transferase 2 (CSGALNACT2)17. These CS glycosyltransferases collabo-
ratively catalyze CS chain initiation and polymerization through their
glycosyltransferase-I and glycosyltransferase-II activities, respectively.
The CS sulfotransferases, including chondroitin-4-O-sulfotransferase
(C4ST) and chondroitin-6-O-sulfotransferase (C6ST) modify the CS
chains by sulfation18,19. Their biochemical characteristics have been
validated both in vitro and in vivo. Recent studies using knockoutmice
models have illuminated the roles of these proteins in vivo. For
example, Csgalnact1-null mice exhibit slight dwarﬁsm with shorter
and disorganized chondrocyte columns in the growth plate10, and
Css1/Chsy1-nullmice suffer fromchondrodysplasia andbrachypodism
with a patterning defect in distal phalanges20. Loss-of-function mu-
tations at the CSS1/CHSY1 locus have been recently identiﬁed in pa-
tients with syndromic recessive preaxial brachydactyly characterized
by shortening or absence of the middle phalanges21,22. These obser-
vations suggest that CS plays important roles in skeletogenesis and
chondrogenesis, and alterations of CS glycosyltransferase expression
or CS structuremay inﬂuence OA progression. Aggrecanmust contain
sufﬁcient amounts of CS to maintain cartilage function, and its prote-
olysis by a disintegrin and metalloproteinase with thrombospondin
motif-4 (ADAMTS)-4 and ADAMTS-5 or matrix metalloproteinases
(MMPs) is stronglyassociatedwithOAprogression23,24; however, little
is known about the effect on the disease of the structure of CS and its
biosynthesis in cartilage.
In the present study,we found that themeanCS concentration and
chain length were lower and shorter, respectively, in the more
degraded cartilage, and that the levels of expression of mRNAs
encoding the six CS glycosyltransferases decreased in the degraded
cartilage.
Methods
Cartilage samples
This studywas approved by theHuman Ethics Committee of Gifu
University. All patients provided informed consent. Human articular
cartilage samples were acquired from primary end-stage OAFig. 1. A) A representative femoral condyle involved in total knee arthroplasty. Two cartilag
samples are shown, which are stained with Safranin O-Fast Green (original magniﬁcation 40
remote cartilage (n ¼ 24). Values represent the mean and SD.patients and included 24 knees of 24 patients (one man and 23
women) who underwent total knee arthroplasty [mean
age standard deviation (SD): 72.8 8.4 years; range, 51e83 years].
None of the patients had undergone chemotherapy or suffered any
trauma to the knee. OA was diagnosed according to the knee OA
criteria of the American College of Rheumatology25, and all knees
were radiographically categorized into either moderate or severe
groups according to the Kellgren/Lawrence classiﬁcation system26.
Two full-thickness cartilage samples (cylindrical, 8 mm) were
harvested from matched areas of weight-bearing cartilage in the
medial femoral condyle (MFC) and lateral femoral condyle (LFC) for
each of the 24 knees, because the degradation of cartilage generally
initiates at the weight-bearing area in the femoral condyle. The
cartilage samples included the area from the surface of the articular
cartilage to the subchondral bone. Two cartilage samples were
divided into two groups as called lesion and remote cartilage: (1)
lesion cartilage was harvested from the area adjacent to the most
severely degraded cartilage (osteoarthritic area) in which the sub-
chondral bone was exposed, and (2) remote cartilage was a non-
arthritic area or early osteoarthritic area [Fig. 1(A)]. The remaining
full-depth cartilage was removed from the cylindrical sample and
dissected into three portions as follows: 50% for RNA extraction,
25% for histological analysis, and 25% for CS extraction.
Radiology
To assess the femuretibia angle (FTA) as an indicator of knee joint
deformity for patients with OA, coronal radiography was performed
according to the standing semi-ﬂexed protocol before surgery27. The
FTA is the lateral angle created by the intersection between a bisector
of the femoral shaft andabisectorof the tibial shaft,which serves as a
goodmarker for the extent of deformity of the knee. Two orthopedic
surgeonsevaluated theFTA fromthe radiographsofpatientswithOA.
Microscopy
Cartilage samples were ﬁxed in 10% buffered formalin (pH 7.4)
for 24 h and then decalciﬁed with 10% EDTA for 2 weeks. The
samples were then embedded in a parafﬁn block, cut into 5-mme samples were removed from MFC and LFC. At the bottom of this ﬁgure, two cartilage
). B, C) Mean Mankin score and CS concentration in cartilage obtained from lesion and
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dustries) and Fast Green (SigmaeAldrich). The degree of cartilage
degeneration based on the modiﬁed Mankin system was deter-
mined as described previously28.
RNA extraction, reverse transcription, and real-time quantitative
polymerase chain reaction (qPCR)
Immediately after removing the cartilage sample, total RNA was
extracted from the tissue using the RNeasy Lipid Tissue Kit (Qiagen,
Hilden, Germany) according to the manufacturer’s instructions, and
RNA concentrationswere quantiﬁed using a spectrophotometer. The
cDNA templates were synthesized from total RNA using a High Ca-
pacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster
City, CA, USA). The qPCR reactions were performed using SYBR Pre-
mixExTaq II (TaKaRa, Japan)withaThermalCyclerDiceRealTime
System 2 (TakaraBio). Each reaction contained 5 ng of cDNA. The
reactions were incubated in a 96-well optical plate at 95C for 30 s,
followed by 40 cycles of denaturation at 95C for 5 s and annealing
and ampliﬁcation at 56C for 30 s. The mRNA levels were calculated
according to the 2DDCT method using Thermal Cycler Dice Real
Time System 2 Software version 4.02, (TakaraBio). Levels of mRNAs
werenormalized to thatofGAPDH,which encodes glyceraldehyde-3-
phosphate dehydrogenase. The primer sequences used to amplify
CSS1/CHSY1, CHPF, CSS3, CHPF2, CSGALNACT1, CSGALNACT2, aggrecan
(ACAN), xylosyltransferase I (XYLT1), xylosylprotein beta 1,4-
galactosyltransferase, polypeptide 7 (B4GALT7), carbohydrate sulfo-
transferase 11/Chondroitin-4-sulfotransferase-1 (CHST11/C4ST1), car-
bohydrate sulfotransferase 3/Chondroitin-6-sulfotransferase-1 (CHST3/
C6ST1) are presented in Supplemental Table 1.
Extraction and puriﬁcation of CS
GAGs were isolated from cartilage samples (20 mg, wet weight).
Brieﬂy, the samples were treated with 0.2 M NaOH for 16 h at room
temperature, neutralized with 4 M acetate, treated with DNase and
RNase for 2 h at 37C, and digested with 1 mg/ml proteinase K
(Promega, Madison, WI, USA) in 50 mM TriseHCl, pH 8.0, for 2 h at
55C. After centrifugation for 10 min at 10,000 g, samples were
applied to a DEAE Sephacel (GE Healthcare) column equilibrated
with 50 mM TriseHCl, pH 7.5. After washing with 10 column vol-
umes of 50 mM TriseHCl, pH 7.5/0.2 M NaCl, the GAG-rich fractions
were elutedwith three column volumes of 50mMTriseHCl, pH 7.5/
2 M NaCl. The eluate was precipitated with three volumes of 95%
ethanol containing 1.3% potassium acetate. After centrifugation for
30 min at 10,000 g at 4C, the precipitate was resuspended in
11ml of 70% ethanol. After centrifugation at 10,000g for 10min at
4C, the precipitate was dissolved in 200 ml of distilled water.
Analysis of CS content
Ten microliters of the 100-fold diluted GAGs extracted from the
cartilage sample was added to 10 ml of 50 mM TriseHCl, pH 8.0/
0.1 mg/ml bovine serum albumin, 29 ml distilled water, and 10 mU
of chondroitinase ABC (Seikagaku Corporation, Tokyo, Japan), and
incubated for 1 h at 37C. After ﬁltering using Ultrafree-MC (5000
molecular weight limit), the composition and concentration of CS
were measured using high-performance liquid chromatography
(HPLC) as described previously10.
Analysis of CS chain length (molecular weight)
An aliquot of the extracted GAGs was labeled with sodium [3H]-
borohydride. Brieﬂy, 1 mg of CS extracted from the sample was
reacted with 8.4 pmol of sodium [3H]-borohydride (12 nCi/pmol)(PerkinElmer Life Sciences) for 3 h at room temperature, treated
with 1 ml of 2M acetate, and neutralizedwith 1 ml of 2MNaOH. Free
sodium [3H]-borohydride was removed by precipitation using
three volumes of 95% ethanol containing 1.3% potassium acetate,
and the labeled sample was applied to a Superose 12 column (GE
Healthcare) equilibrated with 0.2 M ammonium acetate, and the
radioactivity in each fraction was measured as described previ-
ously29. To identify the CS peak in the [3H]-elution proﬁle, 10 mU
chondroitinase ABC (Seikagaku Corporation, Tokyo, Japan) was
added to the same amount of extracted GAGs after being treated as
described above. After incubation for 1 h at 37C and boiling for
1 min, the sample was applied to a Superose 12 column. We
measured the radioactivity of CS by treating the extracted GAG
solutionwith chondroitinase ABC [Supplemental Fig. 1(A)]. The size
of a single representative radioactive GAG peak was reduced by
chondroitinase ABC treatment, verifying that the peak represented
CS. The radioactivity of the GAG solution treated with chon-
droitinase ABC eluted as two peaks (27 and 31 min). The smaller
peak at 27 min represented a short oligosaccharide that was not
digested chondroitinase ABC, whereas the CS cleavage products
generated the peak at 31 min.Calculation of the mean CS chain length (molecular weight)
CS radioactivity was determined after chondroitinase ABC
treatment of the extracted GAG solution. The mean molecular
weight of CS present in cartilage was calculated from the radioac-
tivity of the CS peak and its molecular weight that was determined
according to a calibration curve of CS standards described previ-
ously [Supplemental Fig. 1(B)]30. In order to generate a calibration
curve for CS chain sizes of standards and elution time, low mo-
lecular weight CS standards were produced from the CS of shark
cartilage by a brief acid treatment with (0.4 M HCl, 60C) followed
by gel ﬁltration chromatography, and the average molecular
weights of CS standards were determined using a laser light scat-
tering photometer31.Statistical analysis
Statistical analyses were performed using GraphPad Prism 5.0
software (GraphPad Software, Inc., San Diego, CA). D’Agostinoe
Pearson omnibus normality tests were performed to test for normal
distribution of the data. The data of Mankin score, CS concentration
and CS chain length of lesion and remote cartilage passed the
normality tests, and these differences between lesion and remote
cartilage were determined by using two-tailed paired t-test. Ac-
cording to D’AgostinoePearson omnibus normality tests, the most
data of relative gene expressions (CHPF, CSS3, CHPF2, CSGALNACT1,
CSGALNACT2, ACAN, XYLT1, B4GALT7, C4ST1, C6ST1) were not satis-
ﬁed the assumption of normality, therefore the data of relative gene
expressions differences between both cartilages were determined
by using Wilcoxon matched pairs signed rank sum test. The para-
metric data are presented in the text as mean  SD, and the non-
normal distribution data as median with interquartile range. A P
value <0.05 was considered signiﬁcant.
As the age and FTA showed the normal distribution, Pearson’s
correlation coefﬁcient analysis followed by linear regression anal-
ysis was performed to assess the correlations between age and CS
chain length, CS concentration in each lesion and remote cartilage,
and the correlations between FTA and CS chain length, CS con-
centration in each MFC and LFC.
To generate a standard curve for determining the molecular
weight of CS relative to the elution positions of the CS standards
from the gel chromatography column, simple linear regression
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standards to the logarithmic scale.
Results
Characteristics of the lesion and remote OA cartilage
First, we determined the degree of articular cartilage degrada-
tion according to the modiﬁed Mankin score [Fig. 1(B)]. The mean
Mankin score was signiﬁcantly higher in lesion cartilage compared
with remote cartilage (6.92  3.22 and 4.42  2.36, respectively;
P ¼ 0.0013). The CS concentration in OA cartilage is expressed
relative to the wet weight of cartilage. The mean CS concentration
was signiﬁcantly lower in lesion cartilage (lesion and remote
cartilage, 12.04  5.20 and 14.84  4.86 mg/mg wet weight,
respectively; P¼ 0.021; [Fig.1(C)]). These observations indicate that
the lesion cartilage was more severely degraded.
CS chain length in the lesion and remote cartilages
Next, we determined CS chain length. Fig. 2(A) shows represen-
tative elution proﬁles of CS preparations from lesion and remote
cartilage of the same OA patient, indicating that the mean CS chain
length was shorter in lesion cartilage. The CS chain lengths of all 24
samples shown in Fig. 2(B) varied among individuals. The samples
could be divided into three groups according to CS chain length as
follows: lesion < remote, lesion ¼ remote, and lesion > remote. In
50.0% of all cases (n¼ 12/24), the mean CS chain length was shorterFig. 2. A) Representative elution proﬁles of [3H]-labeled CS preparations from cartilages of th
the CS solution of lesion cartilage shows a peak on 25 min and also a slight shoulder on 2
shoulder on 27 min may represent a short oligosaccharide in human cartilage. B) This bar g
lesion and remote cartilage of each knee. C) The graph shows the mean CS chain length foin the lesion cartilage, whereas it was longer in lesion cartilage in
16.7% of all cases (n ¼ 4/24), and the mean CS chain length was
signiﬁcantly shorter in lesion cartilage (lesion cartilage: 5.36 1.46,
remote cartilage: 6.19  1.84 kDa; P ¼ 0.026; [Fig. 2(C)]).
Gene expression in the lesion and remote cartilage
We reasoned that the expression of mRNAs encoding CS glyco-
syltransferases might be associated with differences in CS concen-
tration and CS chain length between the two types of cartilage.
Therefore, we determined the expression levels of mRNAs encoding
CS glycosyltransferases and others related to CS biosynthesis (ACAN,
XYLT1, B4GALT7, C4ST1, C6ST1) in lesion and remote cartilage using
qPCR [Figs. 3 and 4]. All six CS glycosyltransferase genes were
expressed at lower levels in lesion cartilage, and particularly CHPF,
CSGALNACT1, and CSGALNACT2were signiﬁcantly down regulated in
lesion cartilage [Fig. 3]. The expression level ofCSGALNACT1 in lesion
cartilage was the most strongly down regulated of the three CS
glycosyltransferase genes, which was by a factor of 0.48 compared
with remote cartilage [lesion cartilage: 0.057 (0.032e0.088), remote
cartilage: 0.12 (0.066e0.22), P ¼ 0.0003]. With regard to the other
gene expressions related to CS biosynthesis, the expression of ACAN
was signiﬁcantly down regulated in lesion cartilage although the
gene expressions of XYLT1, B4GALT7, C4ST1, and C6ST1 showed no
signiﬁcant differences between lesion and remote cartilage [Fig. 4].
These results indicate that CS glycosyltransferase gene correlated
with the degree of cartilage degeneration and might affect the CS
concentration and chain length.e 24 OA knees. Lesion cartilage (B) and remote cartilage (-). The [3H] radioactivity for
7 min. The [3H] radiolabelled CS forms a representative peak on 25 min, and a slight
raph indicates CS chain length for all 24 knees, which includes the CS chain length for
r lesion and remote cartilage.
Fig. 3. Expression mRNAs encoding CS glycosyltransferases in lesion and remote cartilage (n ¼ 24). The data are normalized to GAPDH expression, which are presented by whisker-
box plots. Top and bottom whiskers represent the maximum and minimum observations, respectively. Each Ct value of GAPDH for CS glycosyltransferases is shown as follows in
lesion and remote cartilage, respectively: CSS1 25.07  2.49 and 25.38  1.85, CHPF 25.18  2.71 and 25.52  1.95, CSS3 25.16  2.69 and 25.58  2.03, CHPF2 25.09  2.67 and
25.60  2.08, CSGALNACT1 25.18  2.62 and 25.58  2.03, CSGALNACT2 25.06  2.54 and 25.43  1.88.
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Alterations in the distribution patterns of CS in cartilage may
be important, because the levels of chondroitin-4-sulfate (C4S)
and chondroitin-6-sulfate (C6S) in joint ﬂuids are used as
markers of cartilage metabolism, and the C6S level in synovial
ﬂuid may be a valuable indicator of cartilage destruction32.
Therefore, we determined the CS compositions of lesion and
remote cartilage using HPLC (Table I). The proportion of C6S was
dominant (approximately 72%) compared with the levels of C4S
and chondroitin-0-sulfate (C0S) in both cartilages. In lesionFig. 4. Expression of genes related to CS metabolism (ACAN, XYLT1, B4GALT7, C4ST1, C6ST1)
which are presented by whisker-box plots. Top and bottom whiskers represent the maxim
transferases is shown as follows in lesion and remote cartilage, respectively: ACAN 25.18 
25.87  2.14, C4ST1 25.26  2.94 and 25.87  2.14, C6ST1 25.26  2.94 and 25.87  2.14.cartilage, the total amounts of C0S and C4S were signiﬁcantly
lower.
Correlation between the structure of CS and age
Plaas et al.33 found that the average CS chain size in normal
cartilage decreased after skeletal maturity. Therefore, we deter-
mined whether the concentration and chain length of CS correlated
with the age of the patients studied here [Fig. 5(A) and (B)]. In each
lesion and remote cartilage, the age had a signiﬁcant inverse cor-
relation with CS chain length (lesion cartilage: r ¼ 0.47, P ¼ 0.020,in lesion and remote cartilage (n ¼ 24). The data are normalized to GAPDH expression,
um and minimum observations, respectively. Each Ct value of GAPDH for CS glycosyl-
2.68 and 25.51  2.05, XYLT1 25.26  2.94 and 25.87  2.14, B4GALT7 25.26  2.94 and
Table I
CS composition in lesion and remote cartilage
Lesion cartilage
(n ¼ 24)
Remote cartilage
(n ¼ 24)
P value
C0S (mg/wet weight: mean  SD) 1.38  0.88 1.72  0.72 0.021
C4S (mg/wet weight: mean  SD) 1.93  0.94 2.46  0.77 0.023
C6S (mg/wet weight: mean  SD) 8.59  4.12 10.5  4.12 0.053
C6S/C4S ratio (mean  SD) 4.92  1.97 4.32  1.50 0.27
Bold numbers indicate statistically signiﬁcant differences between lesion and
remote cartilage.
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with CS concentration. The CS chain length was shorter in lesion
cartilage [Fig. 2(C)], indicating that shorter CS chains were present
in degraded cartilage. Therefore, these ﬁndings suggest that the CS
chain length becomes shorter with the degradation of cartilage and
with the age.Variation in CS concentration and chain length with the degree of
knee deformity
We assessed whether CS concentration and chain length
correlated with the FTA, which represents the deformity of the
knee at each MFC and LFC. At MFC, the FTA had a signiﬁcant inverse
correlation with CS chain length (r ¼ 0.47, P ¼ 0.022; [Fig. 6(A)]).
Whereas, at LFC, the FTA had no signiﬁcant correlations with CS
levels [Fig. 6(B)].Discussion
We show here that cartilage degradation was more severe in
lesion cartilage and that CS concentration and chain length were
lower and smaller in lesion cartilage. Further, the levels of mRNAs
encoding CS glycosyltransferases were lower in lesion cartilage.
Aggrecan with abundant CS is structurally heterogeneous dur-
ing OA progression or aging. Its keratin sulfate and CS composition
increases and decreases, respectively34, and the core protein of
aggrecan is cleaved by ADAMTS-4, -5, MMPs24,35, and m-calpain36.
However, there are few studies on the variation of the CS structureFig. 5. A) Correlations between age and the CS concentration, CS chain length in lesion cartil
B) Correlations between age and the CS concentration, CS chain length in remote cartilageand CS biosynthesis in OA cartilage, although CS chain length in
normal cartilage decreases with age6,33. We show here that the CS
chain length and concentration were approximately 13.4% shorter
and 18.9% less, respectively, in the more degraded cartilage.
Concerning the reduction of CS concentration and chain length
in the more degraded cartilage, we attribute the reduction of CS
concentration to cleavage of the aggrecan core protein by ADAMTS-
4, -5, and MMPs23,24. Although we did not determine the mecha-
nism responsible for altering CS chain length in OA cartilage, we
suggest that it involves an imbalance in CS metabolism in cartilage,
namely either enhancing the catabolic capacities of chondrocytes
toward CS chain or decreasing the anabolic capacities of chon-
drocytes toward it in OA cartilage. Regarding anabolic capacity, we
found here that expression levels of CS glycosyltransferase mRNAs
(CHPF, CSGALNACT1, and CSGALNACT2) were signiﬁcantly down
regulated in lesion cartilage, although we did not determine the
enzymatic activities of CS glycosyltransferases in cartilage. Their
biochemical roles of these CS glycosyltransferases have been
established by in vitro studies. CSS1 exhibits the highest
glycosyltransferase-II activity, followed by CHPF, CSS3, and CHPF2,
and formation of heteromers between any two of these enzymes is
required to polymerize CS12,13,15. The heterodimer of CSS1 and CHPF
exhibits the highest glycosyltransferase-II activity15,37, and CSGAL-
NACT1 and CSGALNACT2 are mainly responsible for initiating CS
synthesis17,38e40. Taken together, the reductions of CHPF mRNA
levels in lesion cartilagemay reﬂect the decrease in CS chain length,
and the reduction of CSGALNACT1 and CSGALNACT2 expression may
contribute to the decrease in CS chain length in lesion cartilage by
inhibiting new CS biosynthesis. Regarding catabolism, CS catabolic
enzymes in cartilage have not been identiﬁed, although hyaluron-
idase 4 is a candidate; however, its expression is limited to placenta,
skeletal muscle, and testis41.
With regard to changes in the structure and biosynthesis of CS in
OA cartilage, CSGALNACT1 is a critical enzyme for CS biosynthesis
in cartilage42, and Csgalnact1-null mice that express CS at 50% level
of the wild-type level in cartilage exhibit slight dwarﬁsm and
changes to the ECM in cartilage such as decreased levels and rapid
catabolism of aggrecan, and abnormally aggregated type-II collagen
ﬁbers, which resemble the properties of cartilage in OA10. More-
over, Css1/Chsy1-null mice display chondrodysplasia andage. Each Scattergram includes the data of 24 cartilages harvested from lesion cartilage.
. Each Scattergram includes the data of 24 cartilages harvested from remote cartilage.
Fig. 6. A) Correlations between FTA and the CS concentration, CS chain length in OA cartilage obtained fromMFC. Each Scattergram includes the data of 24 cartilages harvested from
MFC. B) Correlations between FTA and the CS concentration, CS chain length in OA cartilage from LFC. Each Scattergram includes the data of 24 cartilages harvested from LFC.
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null mice that express CS at 80% of the wild-type level in cartilage
display no skeletal phenotypes, including articular degradations in
the knee joint, although the amount of CS and its chain length
decrease in cartilage43. This may account for the differences in the
abilities between Css1/Chsy1-null mice and Chpf-null mice to syn-
thesize CS. Analysis of Css1/Chsy1 and Chpf double-knockout mice
may provide further insights into CS metabolism. Taken together,
these mouse studies and our present results indicate that the
ablation or deletion of CS glycosyltransferases leads to a reduction
of CS level and may be associated with OA progression.
Concerning the alteration of CS composition in the degraded
cartilage, in this study, the concentration of C0S and C4S was lower
in lesion cartilage, although the level of C4ST1 mRNA expression
had no differences between two cartilages. Recent in vitro studies
show that 4-0-sulfation of CS requires CS polymerization44, and
C4ST1 null mice with a 90% reduction of C4S compared with wild-
type exhibit severe chondrodysplasia and a disorganized cartilage
growth plate45. These observations support the conclusion that
reduced CS levels inﬂuence OA progression.
With regard to the relationship between biosynthesis of linkage
site of CS and OA progression, it has been reported that XYLT1
regulates GAG biosynthesis during OA progression, and XYLT1
expression is down regulated in late-stage OA46. However, in this
study, the expression of XYLT1 showed no differences between two
cartilages.
Mechanical stress on cartilage is an important factor that in-
ﬂuences CS biosynthesis. Exercise and injury induces structural
changes in CS in cartilage and synovial ﬂuid, and CS chain length in
synovial ﬂuid increases after exercise and osteochondral injury47,48.
In the present study, we evaluated the relationship between knee
deformity and CS structure. FTA is generally an indicator of the
degree for knee deformity, and GAG concentration decreases with
increasing FTA at MFC in human OA cartilage49. We found here that
the CS chain length exhibited an inverse correlationwith the FTA at
MFC, and the CS concentration showed a similar trend. Because an
increase of the FTA represents a worsening of the knee varus in
which weight-bearing shifts to MFC, our results suggest that this
negatively effects on CS biosynthesis.Our study has some limitations. First, although macroscopically
normal or early OA cartilage as remote cartilage was obtained from
patients who underwent knee surgery, complete intact cartilage
could not be collected. Therefore, data regarding CS structure and
gene expression in intact cartilage are lacking. However, based on
comparisons of macroscopically normal or early OA cartilage with
the degraded cartilage, we did ﬁnd some differences regarding CS
structure in OA cartilage. Second, although the expression of
mRNAs encoding CS glycosyltransferases was determined using
qPCR, the actual enzymatic activity of CS glycosyltransferases in OA
cartilage could not be estimated by our protocol.
In summary, the CS in aggrecan exhibited varied structural
changes according to its location in OA cartilage. Thus, the mean CS
concentration (speciﬁcally of C0S and C4S) and CS chain length
decreased in the more degraded cartilage. These structural alter-
ations to CS might be affected by down regulation of CS glycosyl-
transferase gene expression in the OA cartilage. In the future,
manipulating CS glycosyltransferase gene expression in cartilage
might aid in the maintenance of CS chain length and utilized as a
treatment option for OA.
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